Anti-ZDHHC11B monoclonal antibody

Pre-made anti-ZDHHC11B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZDHHC11B/ZDHHC11B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2298-Ab-1/ GM-Tg-hg-IP2298-Ab-2Anti-Human ZDHHC11B monoclonal antibodyHuman
GM-Tg-rg-IP2298-Ab-1/ GM-Tg-rg-IP2298-Ab-2Anti-Rat ZDHHC11B monoclonal antibodyRat
GM-Tg-mg-IP2298-Ab-1/ GM-Tg-mg-IP2298-Ab-2Anti-Mouse ZDHHC11B monoclonal antibodyMouse
GM-Tg-cynog-IP2298-Ab-1/ GM-Tg-cynog-IP2298-Ab-2Anti-Cynomolgus/ Rhesus macaque ZDHHC11B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2298-Ab-1/ GM-Tg-felg-IP2298-Ab-2Anti-Feline ZDHHC11B monoclonal antibodyFeline
GM-Tg-cang-IP2298-Ab-1/ GM-Tg-cang-IP2298-Ab-2Anti-Canine ZDHHC11B monoclonal antibodyCanine
GM-Tg-bovg-IP2298-Ab-1/ GM-Tg-bovg-IP2298-Ab-2Anti-Bovine ZDHHC11B monoclonal antibodyBovine
GM-Tg-equg-IP2298-Ab-1/ GM-Tg-equg-IP2298-Ab-2Anti-Equine ZDHHC11B monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2298-Ab-1/ GM-Tg-hg-IP2298-Ab-2; GM-Tg-rg-IP2298-Ab-1/ GM-Tg-rg-IP2298-Ab-2;
GM-Tg-mg-IP2298-Ab-1/ GM-Tg-mg-IP2298-Ab-2; GM-Tg-cynog-IP2298-Ab-1/ GM-Tg-cynog-IP2298-Ab-2;
GM-Tg-felg-IP2298-Ab-1/ GM-Tg-felg-IP2298-Ab-2; GM-Tg-cang-IP2298-Ab-1/ GM-Tg-cang-IP2298-Ab-2;
GM-Tg-bovg-IP2298-Ab-1/ GM-Tg-bovg-IP2298-Ab-2; GM-Tg-equg-IP2298-Ab-1/ GM-Tg-equg-IP2298-Ab-2
Products NameAnti-ZDHHC11B monoclonal antibody
Formatmab
Target NameZDHHC11B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZDHHC11B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2298-Ag-1Recombinant multi-species ZH11B/ ZDHHC11B/ DHHC-11B protein


    Target information

    Target IDGM-IP2298
    Target NameZDHHC11B
    Gene ID653082
    Gene Symbol and SynonymsDHHC-11B,ZDHHC11B
    Uniprot AccessionP0C7U3
    Uniprot Entry NameZH11B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000206077
    Target ClassificationN/A

    The target: ZDHHC11B, gene name: ZDHHC11B, also named as DHHC-11B. Predicted to enable protein-cysteine S-palmitoyltransferase activity. Predicted to be involved in several processes, including antiviral innate immune response; peptidyl-L-cysteine S-palmitoylation; and positive regulation of defense response to virus by host. Predicted to be located in endosome membrane. Predicted to be active in Golgi apparatus and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.